Fig. 1From: The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidenceCirculation of respiratory viruses detected by the Liguria regional reference laboratory in the three RSV epidemic seasons (2014–2015, 2015–2016 and 2016–2017): data related to RSV are reported in green columnsBack to article page